News

Mission

The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

PROX1/α-SMA Correlated With Colorectal Cancer Progression, Poor Outcomes and Therapeutic Resistance

News

February 7, 2024

PRESS RELEASE: A new research paper was published in Aging's Volume 16, Issue 2, entitled, “PROX1 interaction with α-SMA-rich cancer-associated fibroblasts facilitates colorectal cancer progression and correlates with poor clinical outcomes and therapeutic resistance.” continue reading »

Evaluation of Ruxolitinib, a Janus Kinase Inhibitor, in Multiple Myeloma

News

February 7, 2024

PRESS RELEASE: On February 5, 2024, a new research perspective was published in Oncotarget, entitled, “Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma.” continue reading »

Epigenetic Drift Underlies Epigenetic Clock Signals, but…

Aging

February 6, 2024

PRESS RELEASE: A new research paper was published in Aging's Volume 16, Issue 2, entitled, “Epigenetic drift underlies epigenetic clock signals, but displays distinct responses to lifespan interventions, development, and cellular dedifferentiation.” continue reading »

Drug Discovery in Academia; Dumping in the Publication Landfill?

News

February 5, 2024

PRESS RELEASE: On January 24, 2024, a new editorial was published in Oncotarget, entitled, “The fate of drug discovery in academia; dumping in the publication landfill?” continue reading »

Prognostic Significance of Senescence-related TME Genes in Head and Neck Squamous Cell Carcinoma

Aging

January 31, 2024

PRESS RELEASE: A new research paper was published on the cover of Aging’s Volume 16, Issue 2, entitled, “Prognostic significance of senescence-related tumor microenvironment genes in head and neck squamous cell carcinoma.” continue reading »

« Previous 1 … 35 36 37 38 39 … 102 Next »